Security record · archived quarter
OCUL
Ocular Therapeutix, Inc. · Healthcare · Biotechnology
8Tracked holders
—Δ holders
16.30MShares held
$111.49MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | -8 | 115.87M | $1.14B | +4 | −12 |
| Q1 2026 | 101 | +4 | 114.41M | $983.07M | +11 | −8 |
| Q4 2025 | 96 | +1 | 115.21M | $1.40B | +2 | — |
| Q3 2025 | 18 | 0 | 82.57M | $965.26M | +1 | −1 |
| Q2 2025 | 15 | +1 | 57.50M | $533.65M | +1 | — |
| Q1 2025 | 11 | 0 | 20.34M | $149.08M | +1 | −1 |
| Q4 2024 | 11 | +1 | 19.58M | $167.25M | +2 | −1 |
| Q3 2024 | 9 | +1 | 15.07M | $131.15M | +1 | — |
| Q2 2024 | 8 | — | 16.30M | $111.49M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 4.05M | — | $27.73M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 3.70M | — | $25.27M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.45M | — | $23.62M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 3.45M | — | $23.62M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 2.71M | — | $18.51M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.11M | — | $7.60M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 1.11M | — | $7.60M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 536.12K | — | $3.67M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 429.59K | — | $2.94M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 429.59K | — | $2.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 314.55K | — | $2.15M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 314.55K | — | $2.15M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 266 holders, 206.22M shares, $1.70B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API